Aptorum Group Ltd Cl A (APM)
$2.63 0.06 (2.23%)
19:15 EST APM Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap -
PE Ratio -
Volume (Avg. Vol.) 102,200
Day's Range 2.57 - 2.78
52-Week Range 1.16 - 14.23
Dividend & Yield N/A (N/A)
APM Stock Predictions, Articles, and Aptorum Group Ltd Cl A News
- From InvestorPlace
- From the Web
Aptorum (APM) stock is on the rise Wednesday after announcing approval to move forward with a clinical trial of its staph infection drug.
Aptorum Group got a boost when the company jumped into the Covid-19 conversation. APM stock looks like a late entry into crowded field.
APM stock is a risky name, but the company's recent deal with Singapore has potentially given it a huge opportunity in Asia.
APM stock remains a highly speculative bet for investors as the small biotech company comes with significant risk and volatility.
APM stock mostly flew under the radar among biotechnology investors. After a recent price surge, though, the stock is now an attention getter.
APM stock is soaring on news that Aptorum Group is launching a subsidiary focused on liquid biopsies for infectious diseases.
Navellier RatingsPowered by Portfolio Grader